An HIV Diagnostic Testing Algorithm Using the cobas HIV-1/HIV-2 Qualitative Assay for HIV Type Differentiation and Confirmation-Reference-Cited by-同舟云学术

An HIV Diagnostic Testing Algorithm Using the cobas HIV-1/HIV-2 Qualitative Assay for HIV Type Differentiation and Confirmation

Published:2021-06-18 Issue:7 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Duncan Dana¹,Duncan John¹,Kramer Bastian²,Nilsson Alex Y.²,Haile Betiel¹,Butcher Ann¹,Chugh Shikha¹,Baum Paul¹,Aldrovandi Grace M.³,Young Stephen⁴,Avery Ann K.⁵,Tashima Karen⁶,Valsamakis Alexandra¹,Yao Joseph D.⁷,Chang Ming⁸,Coombs Robert W.⁸⁹

Affiliation:

1. Roche Molecular Systems, Pleasanton, California, USA

2. Roche Molecular Systems, Basel, Switzerland

3. Department of Pediatrics, University of California, Los Angeles, Los Angeles, California, USA

4. TriCore Reference Laboratories, Albuquerque, New Mexico, USA

5. MetroHealth, Cleveland, Ohio, USA

6. The Miriam Hospital, Providence, Rhode Island, USA

7. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

8. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA

9. Department of Medicine, University of Washington, Seattle, Washington, USA

Abstract

Human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) diagnostic testing algorithms recommended by the Centers for Disease Control involve up to three tests and rely mostly on detection of viral antigen and host antibody responses. HIV-1 p24 antigen/HIV-1/HIV-2 antibody-reactive specimens are confirmed with an immunochromatographic HIV-1/HIV-2 antibody differentiation assay, and negative or indeterminate results from the differentiation assay are resolved by an HIV-1-specific nucleic acid amplification test (NAT).

Funder

Roche Holding | Roche Diagnostics

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.03030-20

Reference30 articles.

1. 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2

2. Update on Human Immunodeficiency Virus (HIV)-2 Infection

3. Antiretroviral drug resistance in non-subtype B HIV-1, HIV-2 and SIV;Parkin NT;Antivir Ther,2004

4. Centers for Disease Control and Prevention. 2014. Laboratory testing for the diagnosis of HIV infection: updated recommendations. https://stacks.cdc.gov/view/cdc/23447. Accessed 20 August 2019.

5. Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010–2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and Risks of HIV Infection, Medication Options, and Adverse Effects in Accidental Needle Stick Injuries: A Narrative Review;Cureus;2024-01-02

2. Reflex Human Immunodeficiency Virus (HIV) Type 1 RNA Testing Enables Timely Differentiation of False-Positive Results From Acute HIV Infection;Open Forum Infectious Diseases;2023-12-12

3. Reducing time to new HIV diagnosis: time for change in the HIV diagnostic algorithm?;Pathology;2023-08

4. Laboratory diagnosis of HIV: a contemporary overview in the Australian context;Pathology;2023-08

5. Efficacy and Safety of Two-Drug Regimens That Are Approved from 2018 to 2022 for the Treatment of Human Immunodeficiency Virus (HIV) Disease and Its Opportunistic Infections;Microorganisms;2023-05-31